Results 171 to 180 of about 13,918 (210)
Computed tomography-based prediction of early recurrence risks with estimating individual times to recurrence for lung cancer patients prior to radiotherapy. [PDF]
Kodama T +9 more
europepmc +1 more source
Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysis. [PDF]
Spindler NJ +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet, The, 2019
BACKGROUND The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled trials to support this paradigm is scarce.
Stewart Gaede +2 more
exaly +2 more sources
BACKGROUND The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled trials to support this paradigm is scarce.
Stewart Gaede +2 more
exaly +2 more sources
Radiotherapy and Oncology, 2023
BACKGROUND AND PURPOSE Stereotactic ablative radiotherapy (SABR) for oligometastases may improve survival, however concerns about safety remain. To mitigate risk of toxicity, target coverage was sacrificed to prioritize organs-at-risk (OARs) during SABR ...
Islam Mohamed +2 more
exaly +2 more sources
BACKGROUND AND PURPOSE Stereotactic ablative radiotherapy (SABR) for oligometastases may improve survival, however concerns about safety remain. To mitigate risk of toxicity, target coverage was sacrificed to prioritize organs-at-risk (OARs) during SABR ...
Islam Mohamed +2 more
exaly +2 more sources

